Completed

Auri Super Mushroom Gummies for Cognitive Health in Adults

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Auri Super Mushroom Daily Gummies

Dietary Supplement
Who is being recruted

Mental Disorders+1

+ Cognition Disorders

+ Neurocognitive Disorders

Over 30 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: April 2025
See protocol details

Summary

Principal SponsorAuri Nutrition
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: April 3, 2025

Actual date on which the first participant was enrolled.

This study focuses on exploring how a supplement, specifically Auri Super Mushroom Daily Gummies, impacts cognitive health. The trial is designed for 35 adults and will run over an 8-week period. By examining how these gummies affect aspects such as memory, mood, energy, and overall well-being, the study aims to provide insights that could lead to improved cognitive health strategies. Addressing these areas is important as they can significantly affect daily life, and finding effective ways to enhance them could benefit many people. In the study, participants will take two gummies each day. The trial is virtual, meaning participants can complete it from their homes without needing to travel to a clinic. To measure the effects of the gummies, participants will undergo cognitive tests and fill out self-assessment questionnaires. These assessments will evaluate any changes in their cognitive performance, energy levels, mood, memory, and overall well-being throughout the study duration. This process helps to understand the supplement's potential benefits or risks on cognitive health.

Official TitleA Clinical Trial to Evaluate the Effects of a Supplement on Cognitive Health
Principal SponsorAuri Nutrition
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

35 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 30 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersCognition DisordersNeurocognitive DisordersCognitive Dysfunction

Criteria

Inclusion Criteria: * Be male or female * Be aged 30+ * Anyone who has been experiencing issues consistently for the last four weeks regarding all of the following: Forgetfulness Inability to focus Low energy levels Low mood * Anyone who is generally healthy - does not live with any uncontrolled chronic disease * Willing to stop any other products or any medication or supplements that target cognition or cognitive health for the study duration * Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study * Not undergone any surgeries or invasive treatments in the last six months * Not had any major illness in the last three months * Resides in the United States * Not currently partaking in another research study and will not be partaking in any other research study for the next 8 weeks and at any point during this study's duration * Willing to consult with their healthcare provider before enrolling in the study if taking any prescription medication Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone with any allergies or sensitivities to any of the study product ingredients * Anyone taking immunosuppressants * Anyone taking blood thinners (anticoagulants) * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period) * Anyone unwilling to follow the study protocol * Anyone with a history of substance abuse * Anyone with intolerance or sensitivity to mushrooms

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Participants will take two Auri Super Mushroom Daily Gummies each morning for 8 weeks with their first meal and a glass of water.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Citruslabs

Las Vegas, United StatesOpen Citruslabs in Google Maps
CompletedOne Study Center